DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02190 ZYLOXTB

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Jonathon Zhong Zhao & Associates (22.69%)
OrbiMed Advisors IV Limited (7.77%)
Future Industry Investment Fund (Limited Partnership) (6.28%)
Lake Bleu Capital (Hong Kong) Limited (5.54%)
Zhang Wei (5.02%)		 Sector Health Care & Biotechnology
Web Site http://www.zyloxtb.com Tel (86 571) 8861-0082
Email info@zyloxtb.com Fax N/A
Related Equities N/A
Principal Activities Principally engaged in providing solutions to patients and physicians with the product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top